Novel anti-obesity drugs

Expert Opinion on Investigational Drugs

Volumn 9, Issue 6, 2000, Pages 1317-1326

  Proietto, J ^a   Fam, B C ^a   Ainslie, D A ^a   Thorburn, A W ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Amylin; Leptin; Lipase inhibitor; Melanocortin 4 receptor; MSH agonist; Noradrenergic; NPY antagonist; Ob protein; Obesity; Serotonin; 3 adrenergic receptor agonist

Indexed keywords

AMFEPRAMONE; AMYLIN; ANTIOBESITY AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; FLUOXETINE; GLUCAGON LIKE PEPTIDE; LEPTIN; MAZINDOL; MELANOCORTIN RECEPTOR; NEUROPEPTIDE Y; PHENTERMINE; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE; TETRAHYDROLIPSTATIN;

ADIPOCYTE; BODY WEIGHT; HOMEOSTASIS; HUMAN; NONHUMAN; OBESITY; REVIEW; WEIGHT REDUCTION;

EID: 0034077521     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.9.6.1317     Document Type: Review

References (73)